{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:17:56Z","timestamp":1782515876440,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T00:00:00Z","timestamp":1481500800000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000278","name":"Department for International Development","doi-asserted-by":"publisher","award":["G0100137"],"award-info":[{"award-number":["G0100137"]}],"id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0100137"],"award-info":[{"award-number":["G0100137"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Herpes Simplex Virus 2 (HSV-2) is one of the most common sexually transmitted infections (STIs) worldwide and is a risk factor for the acquisition and transmission of other STIs, including HIV. We determined the prevalence and predictors of HSV-2 infection among women screened for a HIV prevention trial in Durban, South Africa. Univariate and multivariate logistic and Cox regression models were used to determine the correlates and predictors of HSV-2 infection at enrolment and seroconversion during the study respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Prevalence of HSV-2 at screening was 65% and crude incidence was 22.3 per 100 person-years (PY) (95% CI 20.4\u201324.3). The HIV seroconversion was significantly higher among those testing positive for HSV-2 at baseline compared to women who were negative [8.7 per 100 person years (PY) versus 5.2 per 100 PY; (p\u00a0&lt;\u00a00.001)]. In univariate analysis, age was determined to be the most significant predictor for HSV-2 diagnosis, while co-infection with syphilis was also a significant predictor, while age and co-infection with syphilis remained the two most significant predictors of having HSV-2 in multivariate analysis at baseline. Consistent with these results, along with HIV seroconversion, age was also identified as a significant predictor for incidence of HSV-2.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Given the unacceptably high prevalence and incidence rates of HSV-2 infection reported here, HSV-2 and general STI education needs to be reinforced in these communities, with a focus on condom education for prevention. HSV-2 has emerged as the most prevalent STI which is most often asymptomatic and unrecognized, and which increases women\u2019s risk of acquiring other STIs, including HIV.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13104-016-2319-5","type":"journal-article","created":{"date-parts":[[2016,12,12]],"date-time":"2016-12-12T14:18:04Z","timestamp":1481552284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Prevalence of Herpes Simplex Virus 2 (HSV-2) infection and associated risk factors in a cohort of HIV negative women in Durban, South Africa"],"prefix":"10.1186","volume":"9","clinical-trial-number":[{"clinical-trial-number":"isrctn64716212","registry":"10.18810\/isrctn"}],"author":[{"given":"Brodie","family":"Daniels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handan","family":"Wand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gita","family":"Ramjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the MDP Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,12]]},"reference":[{"issue":"6","key":"2319_CR1","first-page":"447","volume":"82","author":"C Celum","year":"2004","unstructured":"Celum C, Levine R, Weaver M, Wald A. Genital herpes and human immunodeficiency virus: double trouble. Bull World Health Organ. 2004;82(6):447\u201353.","journal-title":"Bull World Health Organ"},{"issue":"10","key":"2319_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2471\/BLT.07.046128","volume":"86","author":"KJ Looker","year":"2008","unstructured":"Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ. 2008;86(10):805\u201312 (A).","journal-title":"Bull World Health Organ"},{"issue":"2","key":"2319_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00430-014-0358-x","volume":"204","author":"PA Suazo","year":"2015","unstructured":"Suazo PA, Tognarelli EI, Kalergis AM, Gonz\u00e1lez PA. Herpes simplex virus 2 infection: molecular association with HIV and novel microbicides to prevent disease. Med Microbiol Immunol. 2015;204(2):161\u201376.","journal-title":"Med Microbiol Immunol"},{"issue":"1","key":"2319_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/sti.2006.020966","volume":"83","author":"G Paz-Bailey","year":"2007","unstructured":"Paz-Bailey G, Ramaswamy M, Hawkes SJ, Geretti AM. Herpes simplex virus type 2: epidemiology and management options in developing countries. Sex Transm Infect. 2007;83(1):16\u201322.","journal-title":"Sex Transm Infect"},{"issue":"11","key":"2319_CR5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1258\/ijsa.2012.011433","volume":"23","author":"S Bastien","year":"2012","unstructured":"Bastien S, Mason-Jones A, De Koker P, Mmbaga E, Ross D, Mathews C. Herpes simplex virus type 2 infection as a biomarker for sexual debut among young people in sub-Saharan Africa: a literature review. Int J STD AIDS. 2012;23(11):761\u20136.","journal-title":"Int J STD AIDS"},{"key":"2319_CR6","doi-asserted-by":"publisher","first-page":"a506","DOI":"10.1136\/bmj.a506","volume":"337","author":"R Jewkes","year":"2008","unstructured":"Jewkes R, Nduna M, Levin J, Jama N, Dunkle K, Puren A, Duvvury N. Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. BMJ. 2008;337:a506.","journal-title":"BMJ"},{"issue":"3","key":"2319_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/01.qai.0000144445.44518.ea","volume":"39","author":"G Ramjee","year":"2005","unstructured":"Ramjee G, Williams B, Gouws E, Van Dyck E, De Deken B, Karim SA. The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa. J Acquir Immune Defic Syndr. 2005;39(3):333\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"2319_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13104-015-1093-0","volume":"8","author":"NS Abbai","year":"2015","unstructured":"Abbai NS, Wand H, Ramjee G. Socio-demographic and behavioural characteristics associated with HSV-2 sero-prevalence in high risk women in KwaZulu-Natal. BMC Res Notes. 2015;8(1):185.","journal-title":"BMC Res Notes"},{"issue":"7","key":"2319_CR9","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1086\/597208","volume":"199","author":"J Sobngwi-Tambekou","year":"2009","unstructured":"Sobngwi-Tambekou J, Taljaard D, Lissouba P, Zarca K, Puren A, Lagarde E, Auvert B. Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis. 2009;199(7):958\u201364.","journal-title":"J Infect Dis"},{"issue":"4","key":"2319_CR10","doi-asserted-by":"publisher","first-page":"e5272","DOI":"10.1371\/journal.pone.0005272","volume":"4","author":"JR Lingappa","year":"2009","unstructured":"Lingappa JR, Kahle E, Mugo N, Mujugira A, Magaret A, Baeten J, Bukusi EA, Cohen CR, Katabira E, Ronald A. Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study. PLoS ONE. 2009;4(4):e5272.","journal-title":"PLoS ONE"},{"issue":"11","key":"2319_CR11","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1086\/522006","volume":"196","author":"R Kaul","year":"2007","unstructured":"Kaul R, Nagelkerke NJ, Kimani J, Ngugi E, Bwayo JJ, MacDonald KS, Rebbaprgada A, Fonck K, Temmerman M, Ronald AR. Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis. 2007;196(11):1692\u20137.","journal-title":"J Infect Dis"},{"issue":"5","key":"2319_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa0904849","volume":"362","author":"C Celum","year":"2010","unstructured":"Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med. 2010;362(5):427\u201339.","journal-title":"N Engl J Med"},{"issue":"4","key":"2319_CR13","doi-asserted-by":"publisher","first-page":"e35278","DOI":"10.1371\/journal.pone.0035278","volume":"7","author":"A Nel","year":"2012","unstructured":"Nel A, Mabude Z, Smit J, Kotze P, Arbuckle D, Wu J, van Niekerk N, van de Wijgert J. HIV incidence remains high in KwaZulu-Natal, South Africa: evidence from three districts. PLoS ONE. 2012;7(4):e35278.","journal-title":"PLoS ONE"},{"issue":"4","key":"2319_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1728-4465.2008.00176.x","volume":"39","author":"A Harrison","year":"2008","unstructured":"Harrison A, Cleland J, Frohlich J. Young people\u2019s sexual partnerships in KwaZulu-Natal, South Africa: patterns, contextual influences, and HIV risk. Stud Fam Plann. 2008;39(4):295\u2013308.","journal-title":"Stud Fam Plann"},{"issue":"1300","key":"2319_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1098\/rstb.1993.0143","volume":"342","author":"GP Garnett","year":"1993","unstructured":"Garnett GP, Anderson RM. Factors controlling the spread of HIV in heterosexual communities in developing countries: patterns of mixing between different age and sexual activity classes. Philos Trans R Soc Lond B Biol Sci. 1993;342(1300):137\u201359.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"9749","key":"2319_CR16","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(10)61086-0","volume":"376","author":"S McCormack","year":"2010","unstructured":"McCormack S, Ramjee G, Kamali A, Rees H, Crook AM, Gafos M, Jentsch U, Pool R, Chisembele M, Kapiga S. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet. 2010;376(9749):1329\u201337.","journal-title":"Lancet"},{"issue":"1","key":"2319_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1745-6215-10-99","volume":"10","author":"A Nunn","year":"2009","unstructured":"Nunn A, McCormack S, Crook AM, Pool R, Rutterford C, Hayes R. Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000\/5 for HIV prevention. Trials. 2009;10(1):99.","journal-title":"Trials"},{"issue":"9","key":"2319_CR18","doi-asserted-by":"publisher","first-page":"e42322","DOI":"10.1371\/journal.pone.0042322","volume":"7","author":"U Jentsch","year":"2012","unstructured":"Jentsch U, Lunga P, Lacey C, Weber J, Cairns J, Pinheiro G, Joseph S, Stevens W, McCormack S. The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301). PLoS ONE. 2012;7(9):e42322.","journal-title":"PLoS ONE"},{"issue":"1","key":"2319_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/sti.2009.036541","volume":"86","author":"S Delany-Moretlwe","year":"2010","unstructured":"Delany-Moretlwe S, Jentsch U, Weiss H, Moyes J, Ashley-Morrow R, Stevens W, Mayaud P. Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population. Sex Transm Infect. 2010;86(1):46\u201350.","journal-title":"Sex Transm Infect"},{"issue":"4","key":"2319_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1136\/sti.2010.047142","volume":"87","author":"G de Bruyn","year":"2011","unstructured":"de Bruyn G, Shiboski S, van der Straten A, Blanchard K, Chipato T, Ramjee G, Montgomery E, Padian N. The effect of the vaginal diaphragm and lubricant gel on acquisition of HSV-2. Sex Transm Infect. 2011;87(4):301\u20135.","journal-title":"Sex Transm Infect"},{"issue":"7","key":"2319_CR21","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1097\/00002030-200105040-00009","volume":"15","author":"B Auvert","year":"2001","unstructured":"Auvert B, Ballard R, Campbell C, Cara\u00ebl M, Carton M, Fehler G, Gouws E, MacPhail C, Taljaard D, Van Dam J. HIV infection among youth in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour. AIDS. 2001;15(7):885\u201398.","journal-title":"AIDS"},{"key":"2319_CR22","doi-asserted-by":"publisher","first-page":"ofu043","DOI":"10.1093\/ofid\/ofu043","volume":"1","author":"S Rajagopal","year":"2014","unstructured":"Rajagopal S, Magaret A, Mugo N, Wald A. Incidence of herpes simplex virus type 2 infections in Africa: a systematic review. Open Forum Infect Dis. 2014;1:ofu043.","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"2319_CR23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/OLQ.0b013e31821a6225","volume":"38","author":"HS Okuku","year":"2011","unstructured":"Okuku HS, Sanders EJ, Nyiro J, Ngetsa C, Ohuma E, McClelland RS, Price MA, Graham SM. Factors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behavior. Sex Transm Dis. 2011;38(9):837\u201344.","journal-title":"Sex Transm Dis"},{"issue":"7","key":"2319_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/OLQ.0b013e31816fcaf8","volume":"35","author":"MF Gallo","year":"2008","unstructured":"Gallo MF, Warner L, Macaluso M, Stone KM, Brill I, Fleenor ME, Hook EW III, Austin HD, Lee FK, Nahmias AJ. Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic. Sex Transm Dis. 2008;35(7):679\u201385.","journal-title":"Sex Transm Dis"},{"issue":"5","key":"2319_CR25","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/QAI.0b013e31815b2d9c","volume":"46","author":"D Watson-Jones","year":"2007","unstructured":"Watson-Jones D, Weiss HA, Rusizoka M, Baisley K, Mugeye K, Changalucha J, Everett D, Balira R, Knight L, Ross D. Risk factors for herpes simplex virus type 2 and HIV among women at high risk in northwestern Tanzania: preparing for an HSV-2 intervention trial. J Acquir Immune Defic Syndr. 2007;46(5):631.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2319_CR26","first-page":"130A","volume":"11","author":"A Wald","year":"2004","unstructured":"Wald A. Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes. 2004;11:130A\u20137A.","journal-title":"Herpes"},{"issue":"3","key":"2319_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/QAD.0b013e3282f2aac3","volume":"22","author":"JR Hargreaves","year":"2008","unstructured":"Hargreaves JR, Bonell CP, Boler T, Boccia D, Birdthistle I, Fletcher A, Pronyk PM, Glynn JR. Systematic review exploring time trends in the association between educational attainment and risk of HIV infection in sub-Saharan Africa. AIDS. 2008;22(3):403\u201314.","journal-title":"AIDS"},{"issue":"1","key":"2319_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/ije\/27.1.127","volume":"27","author":"M Van de Laar","year":"1998","unstructured":"Van de Laar M, Termorshuizen F, Slomka M, Van Doornum G, Ossewaarde J, Brown D, Coutinho R, Van den Hoek J. Prevalence and correlates of herpes simplex virus type 2 infection: evaluation of behavioural risk factors. Int J Epidemiol. 1998;27(1):127\u201334.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2319_CR29","doi-asserted-by":"publisher","first-page":"e1001778","DOI":"10.1371\/journal.pmed.1001778","volume":"12","author":"CS Morrison","year":"2015","unstructured":"Morrison CS, Chen PL, Kwok C, Baeten JM, Brown J, Crook AM, Van Damme L, Delany-Moretlwe S, Francis SC, Friedland BA. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. PLoS Med. 2015;12(1):e1001778.","journal-title":"PLoS Med"},{"issue":"4","key":"2319_CR30","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.contraception.2014.07.009","volume":"90","author":"CB Polis","year":"2014","unstructured":"Polis CB, Phillips SJ, Curtis KM, Westreich DJ, Steyn PS, Raymond E, Hannaford P, Turner AN. Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. Contraception. 2014;90(4):360\u201390.","journal-title":"Contraception"},{"issue":"6","key":"2319_CR31","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/QAD.0b013e32835da401","volume":"27","author":"SI McCoy","year":"2013","unstructured":"McCoy SI, Zheng W, Montgomery ET, Blanchard K, van Der Straten A, de Bruyn G, Padian NS. Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa. AIDS. 2013;27(6):1001\u20139.","journal-title":"AIDS"},{"issue":"Suppl 2","key":"2319_CR32","doi-asserted-by":"publisher","first-page":"A65","DOI":"10.1136\/sextrans-2015-052270.177","volume":"91","author":"L Noguchi","year":"2015","unstructured":"Noguchi L, Hillier S, Richardson B, Chirenje Z, Balkus J, Piper J, Marrazzo J. O18. 2 Injectable progestin contraception and acquisition of hsv-2 infection among South African women participating in the voice trial. Sex Transm Infect. 2015;91(Suppl 2):A65.","journal-title":"Sex Transm Infect"},{"issue":"13","key":"2319_CR33","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/archinternmed.2009.177","volume":"169","author":"ET Martin","year":"2009","unstructured":"Martin ET, Krantz E, Gottlieb SL, Magaret AS, Langenberg A, Stanberry L, Kamb M, Wald A. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Arch Intern Med. 2009;169(13):1233.","journal-title":"Arch Intern Med"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-016-2319-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-016-2319-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-016-2319-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:49:59Z","timestamp":1628614199000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-016-2319-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2319"],"URL":"https:\/\/doi.org\/10.1186\/s13104-016-2319-5","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"13 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"510"}}